LIONVILLE, Pa., Sept. 20 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. , the global market leader in closure systems and syringe components for use with injectable drugs, today announced that its Board of Directors approved an increase in its fourth quarter cash dividend to $0.13 per share, an increase of one cent, or 8.3%, over the previous quarter. It is the fourteenth consecutive annual increase to the dividend. The dividend will be paid on November 1, 2006 to shareholders of record on October 18, 2006.
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. is the world’s leading manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. West’s customers include the world’s leading pharmaceutical, biotechnology, generic drug and medical device producers. Internationally headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at http://www.westpharma.com.
West Pharmaceutical Services, Inc.
CONTACT: Michael A. Anderson, Vice President and Treasurer of WestPharmaceutical Services, Inc., +1-610-594-3345; or Investors and FinancialMedia: Julie Huang, or Theresa Kelleher, +1-212-850-5600, wst@fd.com, bothof Financial Dynamics, for West Pharmaceutical Services, Inc.
Web site: http://www.westpharma.com/
